FMX103 minocycline foam 1.5%
Sponsors
Vyne Therapeutics Inc.
Conditions
Facial Papulopustular Rosacea
Phase 3
A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
CompletedNCT03142451
Start: 2017-06-02End: 2018-09-28Updated: 2021-01-29
A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
CompletedNCT04608500
Start: 2017-06-01End: 2018-07-31Updated: 2021-01-07